Paradigm Biopharmaceuticals's market cap is currently $144.13M. The company's EPS TTM is AU$-0.033; its P/E ratio is ―; Paradigm Biopharmaceuticals is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25
Dec 24
Dec 23
Dec 22
Dec 21
Currency in AUD
Paradigm Biopharmaceuticals Earnings and Revenue History
